Cardiac and vascular structure and function parameters do not improve with alternate nightly home hemodialysis: An interventional cohort study

BMC Nephrology

Volumn 12, Issue 1, 2011, Pages

  Van Eps, Carolyn L ^a,b   Jeffriess, Leanne ^a   Haluska, Brian ^a   Hawley, Carmel M ^a   Coombes, Jeffrey ^b   Matsumoto, Aya ^b   Jeffries, Janine K ^a   Johnson, David W ^a,b   Campbell, Scott B ^a   Isbel, Nicole M ^a   Mudge, David W ^a,b   Marwick, Thomas ^a,b  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Arterial Compliance; Carotid Intima Media Thickness; Diastolic Function; Ejection Fraction; Left Ventricular Hypertrophy; Left Ventricular Mass Index; Nocturnal Hemodialysis; Oxidative Stress

Indexed keywords

CATALASE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE; UREMIC TOXIN;

ADULT; ANTIOXIDANT ACTIVITY; ARTERIAL WALL THICKNESS; ARTERY COMPLIANCE; ARTICLE; AUGMENTATION INDEX; BLOOD PRESSURE REGULATION; BONE METABOLISM; BONE MINERAL; BRACHIAL ARTERY; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CAROTID ARTERY; COHORT ANALYSIS; ENZYME ACTIVITY; FEMALE; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HOME CARE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MINERAL METABOLISM; OXIDATIVE STRESS; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT DURATION; TWO DIMENSIONAL ECHOCARDIOGRAPHY; WEIGHT GAIN; AGED; CHRONIC KIDNEY FAILURE; CIRCADIAN RHYTHM; CLINICAL TRIAL; ECHOCARDIOGRAPHY; ECHOGRAPHY; HEART LEFT VENTRICLE HYPERTROPHY; HEART STROKE VOLUME; HOME DIALYSIS; HOSPITAL MANAGEMENT; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; RISK FACTOR; STANDARD; TREATMENT FAILURE; UREMIA;

ADULT; AGED; APPOINTMENTS AND SCHEDULES; BRACHIAL ARTERY; CAROTID INTIMA-MEDIA THICKNESS; CIRCADIAN RHYTHM; COHORT STUDIES; ECHOCARDIOGRAPHY; FEMALE; HEMODIALYSIS, HOME; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; TREATMENT FAILURE; UREMIA;

EID: 80053447772     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-12-51     Document Type: Article

References (75)

1. Australia and New Zealand Dialysis and Transplant Registry Annual Reports. http://www.anzdata.org.au/v1/annual-reports-download.html
2. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Foley R, Parfrey P, Harnett J, Kent G, Martin C, Murray D, Barre P, Kidney Int 1995 47 1 186 192 10.1038/ki.1995.22 7731145
3. Doppler echocardiography description of diastolic function disorders in terminal renal failure. Josephs W, Odenthal H, Lenga P, Wiechmann H, New characterization of uremic cardiomyopathy, Cardiol Z, 1990 79 482 8
4. Cardiovascular disease in chronic renal failure: Pathophysiologic aspects. London G, Semin Dial 2003 16 2 85-94
5. Cardiac disease in the dialysis patient: Good, better, best clinical practice: Blood Purif. Hampl H, Riedel E, 2009 27 99 113
6. Arterial stiffness and function in end-stage renal disease. London G, Marchais S, Guerin A, Metivier F, Adda H, Nephrol Dial Transplant 2002 17 1713 1724 10.1093/ndt/17.10.1713 12270974 (Pubitemid 35174279)
7. Arterial stiffness and function in End-stage renal disease. London G, Marchais S, Guerin A, Adv Chronic Kidney Dis 2004 11 2 202 209 10.1053/j.arrt.2004.02.008 15216492 (Pubitemid 39295215)
8. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE study. Longencker J, Coresh J, Powe N, Levey A, Fink N, Martin A, Klag M, J Am Soc Nephrol 2002 13 1918 1927 10.1097/01.ASN.0000019641.41496.1E 12089389 (Pubitemid 34700618)
9. Predictors of cardiovascular death in ESRD. Zoccali C, Tripepi G, Mallamaci F, Semin Nephrol 2005 25 6 358 362 10.1016/j.semnephrol.2005.05.002 16298255 (Pubitemid 41655967)
10. Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: Results from the atherosclerosis risk in communities study. Munter P, He J, Astor B, Folsom A, Coresh J, J Am Soc Nephrol 2005 16 529 538 10.1681/ASN.2004080656 15625072 (Pubitemid 41725151)
11. Novel cardiovascular risk factors in end-stage renal disease. Zoccali C, Mallamaci F, Tripepi G, J Am Soc Nephrol 2004 15 77 S80 10.1097/01.ASN. 0000093240.84097.FE 14684678
12. Daily nocturnal home hemodialysis. Pierratos A, Kidney Int 2004 65 1975 1986 10.1111/j.1523-1755.2004.00603.x 15086951 (Pubitemid 38591056)
13. Quotidian dialysis-update 2005. Pierratos A, McFarlane P, Chan C, Current Opinions in Nephrology and Hypertension 2005 14 119 124 10.1097/00041552- 200503000-00006
14. Cardiovascular effects of home intensive hemodialysis. Chan C, Adv Chronic Kidney Dis 2009 16 3 173 178 10.1053/j.ackd.2009.02.003 19393967
15. A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism and health-related quality of life. Walsh M, Culleton B, Tonelli M, Manns B, Kidney Int 2005 67 1500 1508 10.1111/j.1523-1755.2005.00228.x 15780103 (Pubitemid 40463127)
16. The London daily/nocturnal hemodialysis study. Blagg C, Lindsay R, Eds, Am J Kidney Dis 2003 42 Supp 1
17. Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study. Ayus J, Mizani M, Achinger S, Thadhani R, Go A, Lee S, J Am Soc Nephrol 2005 16 9 2778 88 10.1681/ASN.2005040392 16033855
18. Short daily haemodialysis: blood pressure control and left ventricular mass reduction in hypertensive haemodialysis patients. Fagugli R, Reboldi G, Quintaliani G, Pasini P, Ciao G, Cicconi B, Pasticci F, Kaufman J, Buoncristiani U, Am J Kidney Dis 2001 28 2 371 376
19. Effect of frequent nocturnal haemodialysis vs conventional haemodialysis on left ventricular mass and quality of life: A randomized controlled trial. Culleton B, Malsh M, Klarenbach S, Mortis G, Scott-Douglas N, Quinn R, Tonelli M, Donnelly S, Friedrich M, Kumar A, Mahallati H, Hemmelgarn B, Manns B, JAMA 2007 298 11 1291 1299 10.1001/jama.298.11.1291 17878421 (Pubitemid 47443343)
20. Short-term blood pressure, noradrenergic, and vascular effects of nocturnal home hemodialysis. Chan C, Harvey P, Picton P, et al. Hypertension 2003 42 925 931 10.1161/01.HYP.0000097605.35343.64 14557284 (Pubitemid 37413732)
21. Improvement in lower extremity peripheral arterial disease by nocturnal hemodialysis. Chan C, Mardirossian S, Faratro R, et al. Am J Kidney Dis 2003 41 225 229 10.1053/ajkd.2003.50010 12500241 (Pubitemid 36043371)
22. Nocturnal hemodialysis increases arterial baroreflex sensitivity and compliance and normalizes blood pressure of hypertensive patients with end-stage renal disease. Chan C, Jain V, Picton P, et al. Kidney Int 2005 68 338 344 10.1111/j.1523-1755.2005.00411.x 15954925 (Pubitemid 43181393)
23. Recommendations for quantification of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. Schiller N, Shah P, Crawford l, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, schnittger I, J Am Soc Echocardiography 1989 2 358 67
24. Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. Zoccali C, Benedetto F, Mallamaci F, Tripepi G, Giacone G, Caraliotti A, Seminara G, Stancanelli B, Malatino L, J Am Soc Nephrol 2001 12 2768 2774 11729247 (Pubitemid 33115425)
25. A formula to estimate the approximate surface area if height and weight be known. DuBois D, DuBois EF, Arch Intern Medicine 1916 17 863 71
26. A clinical approach to the assessment of left ventricular diastolic function by Doppler echocardiography: update 2003. Ommen S, Nishimura R, Heart 2003 89 Suppl III 18 23 12482783
27. Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. Sorensen K, Celermajer D, Speigelhalter D, Georgakopoulos D, Robinson J, Thomas O, Deanfield J, Br Heart J 1995 74 247 253 10.1136/hrt.74.3.247 7547018
28. Noninvasive tests of vascular function and structure: Why and how to perform them. Fathi R, Marwick T, Am Heart J 2001 141 5 694 703 10.1067/mhj.2001.114972 11320355 (Pubitemid 32378476)
29. Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on FMD response. Bots M, Westerlink J, Rabelink T, Koning E, European Heart Journal 2004 26 4 363 368 15618057 (Pubitemid 40283095)
30. Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. Neutenteufl T, Katzenschlager R, Hassan A, Klaar U, Schwarzacher S, Glogar D, Bauer P, Weidinger F, Atherosclerosis 1997 1111 1118
31. Associations between carotid artery intima-media thickness and cardiovascular risk factors in CKD. Preston E, Ellis M, Kulinskaya E, Davies A, Brown E, Am J Kidney Dis 2005 46 5 856 862 10.1053/j.ajkd.2005.07.048 16253725 (Pubitemid 41505459)
32. Intima-media thickness of carotid artery predicts cardiovascular mortality in hemodialysis patients. Nishizawa Y, Shoji T, Mekawa K, et al. Am J Kidney Dis 2003 41 Suppl 1 76 S79 12612958
33. Cross-sectional association of serum phosphate with carotid intima-medial thickness in hemodialysis patients. Ishimura E, Taniwaki H, Tabata T, Tsujimoto Y, Jono S, Emoto M, Shojo T, Inaba M, Inoue T, Nishizawa Y, Am J Kidney Dis 2005 45 5 859 865 10.1053/j.ajkd.2005.02.008 15861351 (Pubitemid 43181045)
34. Carotid intima-media thickness measurements: what defines abnormality? Aminbakhsh A, Mancini G, A systematic review, Clin Invest Med 1999 22 4 149 57 (Pubitemid 29516419)
35. The relative importance of vascular structure and function in predicting cardiovascular events. Fathi R, Haluska B, Isbel N, Short L, Marwick T, J Am Coll Cardiol 2004 43 4 616 23 10.1016/j.jacc.2003.09.042 14975472 (Pubitemid 38229534)
36. Use of pulse pressure method for estimating total arterial compliance in vivo. Stergiopulos N, Segers P, Westerhof N, Am J Physiol 1999 276 424 H428 9950841
37. Evaluation of methods for estimation of total arterial compliance. Stergiopulos N, Meister JJ, Westerhof N, Am J Physiol 1995 268 1540 H1548 7733355
38. Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. Quinones M, Otto C, Stoddard M, Woggoner A, Zoghbi, Recommendations for quantification of Doppler echocardiography: a report from the Doppler quantification task force of the nomenclature and standards committee of the American Society of Echocardiography, Journal of the American Society of Echocardiography 2002 15 2 167 84
39. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Chen CH, Nevo E, Fetics B, et al. Validation of generalized transfer function, Circulation 1997 95 1827 36 (Pubitemid 27164400)
40. Simple and accurate way for estimating total and segmental arterial compliance: the pulse pressure method. Stergiopulos N, Meister JJ, Westerhof N, Ann Biomed Eng 1994 22 392 7 10.1007/BF02368245 7998684 (Pubitemid 24264086)
41. Relation of arterial stiffness to diastolic dysfunction in hypertensive heart disease. Mottram P, Haluska B, Leano R, Carlier S, Case C, Marwick T, Heart 2005 91 1551 1556 10.1136/hrt.2004.046805 16287739 (Pubitemid 41697593)
42. Measurement of arterial distensibility and compliance to assess prognosis. Haluska B, Jeffries L, Carlier S, Marwick T, Atherosclerosis 2010 209 471 480
43. Estimation of central aortic pressure waveform by mathematical transformation of radial tanometry pressure: validation of generalized transfer function. Chen C, Nevo E, Fetics B, Pak P, Yin F, Maughan W, Kass, Circulation 1997 95 1827 1836 9107170 (Pubitemid 27164400)
44. Aortic input impedance in normal man: relationship to pressure wave forms. Murgo J, Westerhoff N, Giolma J, Altobelli S, Circulation 1980 62 105 116 7379273 (Pubitemid 10083104)
45. Reference values for the augmentation index and pulse pressure in apparently healthy Korean subjects. Chung J, Lee Y, Kim J, Seong M, Kim S, Lee J, Ryu J, Choi J, Lim K, Chang S, Lee G, Kim S, Korean Circ J 2010 40 165 171 10.4070/kcj.2010.40.4.165 20421956
46. In-centre hemodialysis six times per week versus three times per week. The FHN Trial Group, The New England Journal of Medicine 2010 363 24 2287 2300 21091062
47. Effect of Nocturnal Home Hmeodialysis. The FHN Trial Group, Results presented in the Late Breaking clinical Trials session at American society of nephrology Meeting 2010
48. Renal transplantation is not associated with regression of left ventricular hypertrophy: A magnetic resonance study. Patel R, Mark P, Johnston N, McGregor E, Dargie H, Jardine A, CJASN 2008 3 1807 1811 18650407
49. Cardiovascular effects of successful renal transplantation: A 30 month study on left ventricular morphology, systolic and diastolic functions. Dudziak M, Debska-Slizien, Rutkowski B, Transplant Proc 2005 37 2 1039 1043 10.1016/j.transproceed.2004.12.201 15848616 (Pubitemid 40598007)
50. Cardiac performance and morphology in end-stage renal disease. Alpert M, Am J Med Sci 2003 325 4 168 178 10.1097/00000441-200304000-00003 12695722 (Pubitemid 36437990)
51. Nocturnal hemodialysis is associated with restoration of impaired endothelial progenitor cell biology in end-stage renal disease. Chan C, Li S, Verma S, Am J Physiol Renal Physiol 2005 289 679 F684 10.1152/ajprenal.00127. 2005 15928211 (Pubitemid 41324188)
52. Effect of renal transplantation on endothelial function in haemodialysis patients. Kocak H, Ceken K, Yavuz A, Yukel S, Gurkan A, Erdogan O, Ersoy F, Yakupoglu G, Demirbas A, Tuneer M, Nephrology Dialysis and Transplantation 2006 21 203 207 (Pubitemid 43057131)
53. Normalization of endothelial dysfunction following renal transplantation is accompanied by a reduction of circulating visfatin/NAMPT. A novel marker of endothelial damage? Yilmaz M, Saglam M, Carrero J, Qureshi A, Caglar K, Eyileten T, Sonmez A, Oguz Y, Aslan I, Vural A, Yenicesu M, Stenvinkel P, Lindholm B, Axelsson J, Clin Transplant 2009 23 2 241 8 10.1111/j.1399-0012.2008.00921.x 19402217
54. Endothelial function improves with decrease in asymmetric dimethylarginine (ADMA) levels after renal transplantation. Yilmaz M, Saglam M, Caglar K, Cakir E, Ozgurtas T, Sonmez A, Eyileten T, Yenicesu M, Acikel C, Oguz Y, Ozcan O, Bozlar U, Erbil K, Aslan I, Vural A, Transplantation 2005 80 12 1660 6 10.1097/01.tp.0000183750.22675.be 16378057 (Pubitemid 43053988)
55. Endothelial dysfunction and fetuin A levels before and after kidney transplantation. Caglar K, Yilmaz M, Saglam M, Cakir E, Kilic S, Eyileten T, Sonmez A, Oguz Y, Oner K, Ors F, Vural A, Yenicesu M, Transplantation 2007 83 4 392 7 10.1097/01.tp.0000251647.72673.c7 17318070 (Pubitemid 46667841)
56. Kidney Transplantation improves endothelium-dependent vasodilation in patients with end-stage renal disease. Passauer J, Bussemaker E, Lassig G, Gross P, Transplantation 2003 1907 1910 (Pubitemid 36734652)
57. Long-term impact of renal transplantation on carotid artery properties and on ventricular hypertrophy in end stage renal failure patients. De Lima J, Vieira M, Viviani L, Medeiros C, Ianhez L, Kopel L, de Andreda J, Krieger E, Lage S, Nephrol Dial Transplant 2002 17 4 645 51 10.1093/ndt/17.4.645 11917059 (Pubitemid 34308821)
58. Evolution of large-vessel arteriopathy in paediatric patients with chronic kidney disease. Litwin M, Jourdan C, Niemirska A, Schenk J, Jobs K, Grenda R, Wawer Z, Rajszys P, Mehls O, Schaefer F, Nephrol Dial Transplant 2008 23 8 2552 7 10.1093/ndt/gfn083 18344239
59. Arterial function after successful renal transplantation. Zoungas S, Kerr P, Chadban S, Muske C, Ristevski S, Atkins R, McNeill J, McGrath, Kidney Int 2004 65 5 1882 9 10.1111/j.1523-1755.2004.00595.x 15086931 (Pubitemid 38591040)
60. Arterial stiffness after successful renal transplantation. Nishioka T, Akiyama T, Nose K, Koike H, Transplant Proc 2008 40 7 2405 8 10.1016/j.transproceed.2008.07.038 18790249
61. Atherosclerosis after kidney transplantation: changes of intima-media thickness of carotids during early post transplant period. Nafar M, Khatami F, Kardavani B, Farjad R, Pour-Rezagholi F, Firoozan A, Urol J 2007 4 2 105 10 17701931
62. Successful renal transplantation decreases aortic stiffness and increases vascular reactivity in dialysis patients. Covic A, Goldsmityh D, Gusbeth-Totomir P, Buhaescu I, Covic M, Transplantation 2003 76 11 1573 7 10.1097/01.TP.0000086343.32903.A8 14702526 (Pubitemid 37549829)
63. Time dependent effects of cadaveric renal transplantation on arterial compliance in patients with end stage kidney disease. Westhoffg T, Straub-Hohenbleicher H, Basdorf M, van der Giet S, Offerman G, Schlattmann P, Zidek W, van der Giet M, Transplantation 2006 81 10 1410 4 10.1097/01.tp. 0000209418.67546.63 16732178 (Pubitemid 43847151)
64. Effects of an increase in time vs frequency on cardiovascular parameters in chronic haemodialysis patients. Weinreich T, De los Rios T, Passlick-Deetjen J, Clin Nephrol 2006 66 6 433 9 17176915 (Pubitemid 44896152)
65. Arterial stiffness in renal patients: An update. Covic A, Gusbeth-Tatomir P, Goldsmith D, Am J Kidney Diseases 2005 45 6 965 977 10.1053/j.ajkd.2005.02. 026 (Pubitemid 40806509)
66. Predictors of carotid artery intima-media thickness in chronic kidney disease and kidney transplant without overt cardiovascular disease. Yilmaz M, Qureshi A, Carrero J, Saglam M, Suliman M, Caglar K, Eyileten T, Sonmez A, Oguz Y, Vural A, Yenicesu M, Axelsson J, Am J Nephrol 2010 31 3 214 21 10.1159/000272936 20068285
67. Correction of anemia with erythropoietin alp[ha in chronic kidney disease. Singh A, Szczech L, Tang K, Barnhart H, et al. N Eng J Med 2006 355 20 2085 2099 10.1056/NEJMoa065485 (Pubitemid 44749317)
68. A trial of darbepoietin alpha in type 2 diabetes and chronic kidney disease. Pfeffer M, Burdmann E, Chen C, Cooper M, de Zeeuw D, Eckardt K, Feyzi J, Ivanovich P, Kewalramani R, Levy A, et al. N Engl J Med 2009 361 21 2019 32 10.1056/NEJMoa0907845 19880844
69. Atorvastatin in Patients with type 2 diabetes mellitus undergoing hemodialysis. Wanner C, Krane V, Marz W, Olschewski M, Mann J, Ruf G, Ritz E, N Eng J Med 2005 353 238 48 10.1056/NEJMoa043545 (Pubitemid 41058323)
70. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. Fellstrom B, Jardine A, Schmieder R, Holdaas H, Bannister K, Beutler J, Chae D, Chevaile A, Cobbe S, et al. N Eng J Med 2009 360 14 1395 407 10.1056/NEJMoa0810177
71. Increased targeting of cardiovascular risk factors in patients with chronic kidney disease does not improve atheroma burden or cardiovascular function. Isbel N, Haluska B, Johnson D, Beller E, Hawley C, Marwick T, Am Heart J 2006 151 745 53 10.1016/j.ahj.2005.06.017 16504645 (Pubitemid 43290274)
72. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Locatilli F, Canaud B, Eckardt K, Stenvinkel P, Wanner C, Zoccali C, Nephrol Dial Transplant 2003 18 1272 1280 10.1093/ndt/gfg074 12808161 (Pubitemid 36826946)
73. Evolution of oxidative stress and inflammation during hemodialysis and their contribution to cardiovascular disease. Wratten M, Galaris D, Tetta C, Sevanian A, Antiox Redox Signal 2002 4 935 944 10.1089/152308602762197470 (Pubitemid 36042469)
74. Water soluble vitamin levels in home haemodialysis patients. Crowther N, Polkinghorne K, Linehan L, Corradini A, Kerr P, Nephrology 2009 14 Suppl 1 A6 Abstract Nr 20
75. Comparative accuracy of apical biplane cross-sectional echocardiography and gated equilibrium radionuclide angiography for estimating left ventricular size and performance. Starling M, Crawford M, Sorensen S, Levi B, Richards K, O'Rourke R, Circulation 1981 63 1075 1084 10.1161/01.CIR.63.5.1075 7471367 (Pubitemid 11106374)